Tottenham Acquisition I Limited
Status: Deal Closed
U=S+W+R
W=S/2@11.5
R=S/10
| IPO Proceeds, $M | $46.00M |
|---|---|
| IPO Date | Aug 2, 2018 |
| CEO | Jason Ma |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12+3+3+3+3+3+1+1+1+1 |
| IPO Sector |
General
TMT, education, e-commerce, health-care and consumer goods with primary operations in Asia (with an emphasis in China) |
| IPO Geography | Global |
| Target Company | Clene Nanomedicines |
| Deal Announced | Sep 2, 2020 |
| Deal Size, $M | $542.50M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Dec 30, 2020 |
| Amendment Vote | TBD |
| Closing Date | Dec 30, 2020 |
Formerly TOTA
CLNN
CLNNW
| Price | $0.32 |
|---|---|
| Last closing price | $0.33 |
| H/L, today | $0.31 / $0.33 |
| H/L, 52-week | $0.36 / $1.99 |
| Volume, today | 412,056 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | $0.05 |
|---|---|
| Last closing price | $0.05 |
| High/low price, today | $0.04 / $0.05 |
| High/low price, 52-week | $0.03 / $0.21 |
| Volume, today | 115 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Tottenham Acquisition I Limited:
- Structure and cap table
- 5 directors & officers
- 39 filings and events
- 2 underwriters
- 2 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jason Ma | 46 | Chairman, CEO & Director |
| Felix Wong | 52 | CFO & Director |
| Satoshi Tominaga | 39 | Director |
| Albert Lyu | 39 | Director |
| Estela Kuo | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 3,600,000 | units |
| I-Bankers Securities | 400,000 | ||
| 4,000,000 | units | ||
| Up-Front UW fee | 2.50 | % | |
| Deferred UW fee | 4.00 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 39 filings.